quinoxalines has been researched along with mdl 100907 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlsson, A; Carlsson, ML; Martin, P; Waters, N; Waters, S | 1 |
Adell, A; Amargós-Bosch, M; Artigas, F; Bortolozzi, A; Díaz-Mataix, L; Pons, S; Serrats, J | 1 |
Greenshaw, A; Hayes, D; Mosher, T | 1 |
Gorzalka, BB; Hill, MN; Sun, JC | 1 |
Greenshaw, AJ; Hayes, DJ; Mosher, TM | 1 |
Aoyama, T; Hattori, T; Kato, S; Kurosawa, S; Nahata, M; Ohno, S; Ro, S; Sakurada, T; Takabayashi, H; Tamai, M; Yakabi, K; Yuzurihara, M | 1 |
Chaki, S; Fukumoto, K; Iijima, M | 1 |
7 other study(ies) available for quinoxalines and mdl 100907
Article | Year |
---|---|
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Topics: Animals; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Hyperkinesis; Male; Mice; Motor Activity; Piperidines; Quinoxalines; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin; Salicylamides; Serotonin Antagonists | 1997 |
In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminopyridines; Anesthetics, Local; Animals; Antipsychotic Agents; Benzopyrans; Blotting, Western; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Immunohistochemistry; In Situ Hybridization; Indoles; Indophenol; Male; Mice; Mice, Inbred C57BL; Microdialysis; Piperidines; Prazosin; Prefrontal Cortex; Quinoxalines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tetrodotoxin; Thiazoles; Time Factors | 2003 |
Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
Topics: Aminopyridines; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Indoles; Ligands; Male; Motor Activity; Oxadiazoles; Piperazines; Pyrazines; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Time Factors | 2005 |
Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
Topics: Amphetamines; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Endocannabinoids; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Ketanserin; Male; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Kainic Acid; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists | 2005 |
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2009 |
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Topics: Animals; Anorexia; Cisplatin; Drugs, Chinese Herbal; Eating; Gastric Mucosa; Ghrelin; Granisetron; Hypothalamus; Male; Oligopeptides; Ondansetron; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin 5-HT2 Receptor Antagonists; Stomach | 2010 |
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the
Topics: Amino Acids; Animals; Antidepressive Agents; Dioxoles; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Feeding Behavior; Fenclonine; Ketamine; Male; Mice, Inbred C57BL; Neuropsychological Tests; Piperazines; Piperidines; Pyridines; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Ritanserin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Tryptophan Hydroxylase; Xanthenes | 2014 |